L39-12304-46345
3 vaccinations
1 coded response
40 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 198 / DE
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Moderna
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-09
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-05-03
Dose 2 — Moderna
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-08-02
- 2021-11-01
-
2021-11-12
Dose 3 — Moderna
- 2021-11-12
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
- 2022-05-13
-
2022-11-12
Survey response — 12 months, dose 3MedDRA: Blood cholesterol increased, Glucose tolerance impaired, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pre diabetes, high cholesterol · Healthcare visit (other): PCP visitMedDRA releases: 2024-11 · check-in free text available
-
2022-11-12
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Moderna | |
| 2 | 2021-05-03 | Moderna | |
| 3 | 2021-11-12 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Blood cholesterol increased | · | · | ✓ |
| SD | Glucose tolerance impaired | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release